Canadian researchers examined data on 24,625 patients who were diagnosed with rheumatoid arthritis between 1996 and 2006. The compared the data with information on 25,396 controls in the general population.
The study shows individuals with rheumatoid arthritis had a 47 percent greater chance of needing to be hospitalized for COPD than controls. Even after modelling for smoking and varying COPD definitions, the increased risk for the rheumatoid arthritis group remained significant.
“These findings are novel because it has only recently been recognized that inflammation plays a role in the development of COPD, and clinicians treating people with rheumatoid arthritis are not aware that their patients are at increased risk of developing COPD,” said Diane Lacaille, MD, of Arthritis Research Canada and the University of British Columbia, principal investigator of the study.
More articles on healthcare quality:
San Diego VA administers 1.5k ineffective flu shots
Possible norovirus sickens 45 in Hawaii
11M men have oral HPV in US
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
